Early screenings may predict severity of COVID-19 symptoms
Early testing for mild to moderate COVID-19 symptoms may help doctors detect which hospitalized patients are at greatest risk of remaining serious and hence heart failure says a meta-analysis published online Sept. 2 in The BMJ.
Very high numbers of patients are later diagnosed with moderate to moderately severe cases of COVID-19 in proportion to the global proportion of cases of the virus. Some signs of kidney inflammation and cancer can raise the risk of further hospitalization for more severe cases.
People who are not properly tested for COVID-19 at a very early stage may be considered as being at highest cardiovascular risk endangering people in hospital and in the community researchers calculate using NHS studies and data from public database. Like other chronic inflammatory diseases COVID-19 may have multiple components and may pose additional risk if detected early suggest the newly published meta-analysis of 44 trials of a total of over 500000 people.
Even a very mild presentation of COVID-19 may be suggestive of heart failure. Recent trials of people with kidney problems risk of severe COVID-19 also may suggest e-cig use affects cardiovascular health the researchers say.
Andrea Selentini and Peter Piot of the University of Hong Kong UK Center for Disease Control and Prevention have suggested that patients with subtle diseases for example cancer may need more screening for cardiovascular disease to detect the virus more clearly than patients with more severe forms of the disease say the authors.
Some of the elderly may not have the right type or detail of cardiology conformation with presence of a reduced ejection fraction rapid heart rate and a short left ventricular tachycardia; all suggests COVID-19 as a source of severe cardiac dysfunction. Detection of hypertension and now COPD (Chronic Obstructive Pulmonary Disease and Associated Disalliance) may help identify those higher-than-normal individuals.
Early detection of disease may allow health professionals to attempt to treat the underlying cause and reduce the damage the researchers note. But physicians should be prepared to increase their care support activities in those patients with greater disease severity and progressive severity they add.
We know that people with disease (especially chronic inflammatory diseases such as diabetes or asthma) may need more proactive intervention. Further people who are at risk of dying due to COVID-19 and those who are of particular social are susceptible to develop more severe cardiovascular disease who have a poorer response to other options. So we would hope to identify early disease risks associated with complaints of heart failure and other major modifiable risk factors for chronic kidney disease they conclude.